Target Values and Daytime Variation of Bone Turnover Markers in Monitoring Osteoporosis Treatment After Fractures

Autor: Tove T Borgen, Lene B Solberg, Trine Lauritzen, Ellen M Apalset, Åshild Bjørnerem, Erik F Eriksen

Publikováno v: JBMR Plus, Vol 6, Iss 6, Pp n/a-n/a (2022)

ABSTRACT The serum bone turnover markers (BTM) procollagen type 1 N‐terminal propeptide (P1NP) and C‐terminal cross‐linking telopeptide of type 1 collagen (CTX) are recommended for monitoring adherence and response of antiresorptive drugs (ARD)

Externí odkaz: https://doaj.org/article/32dac3793d6f4320820138ef91acabb1

Author response for 'Target Values and Daytime Variation of Bone Turnover Markers in Monitoring Osteoporosis Treatment after Fractures'

Autor: null Tove T Borgen, null Lene B Solberg, null Trine Lauritzen, null Ellen M. Apalset, null Åshild Bjørnerem, null Erik F Eriksen

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::6abff8974f9de5c5991ba3d0f20fddcd
https://doi.org/10.1002/jbm4.10633/v2/response1

Vertebral fractures in a case of pregnancy and lactation-associated osteoporosis

Autor: Shima, Rafey, Lars M, Hübschle, Åshild, Bjørnerem, Tove T, Borgen

Publikováno v: Tidsskrift for den Norske laegeforening : tidsskrift for praktisk medicin, ny raekke. 140(3)

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid________::d538f1ec8a6396543e50f93f1d9e4f6c
https://pubmed.ncbi.nlm.nih.gov/32105038

Development of classification criteria for hand osteoarthritis: comparative analyses of persons with and without hand osteoarthritis.

Autor: Haugen IK; Rheumatology, Diakonhjemmet Hospital, Oslo, Norway ida.haugen@diakonsyk.no., Felson DT; Rheumatology Section, Boston University School of Medicine, Boston, Massachusetts, USA.; Arthritis Research UK Epidemiology Unit and National Institute for Health Research Biomedical Research Centre, The University of Manchester, Manchester, UK., Abhishek A; Academic Rheumatology, School of Medicine, University of Nottingham, Nottingham, UK.; Nottingham NIHR-BRC,Nottingham, UK., Berenbaum F; Department of Rheumatology, Hopital Saint-Antoine,Paris, France., Bierma-Zeinstra S; Department of General Practice, Department of Orthopedics, Erasmus Medical Center, Rotterdam, Netherlands., Borgen T; Rheumatology, Diakonhjemmet Hospital, Oslo, Norway.; Frysja Medical Practice, Oslo, Norway., Herrero Beaumont G; Rheumatology, Universidad Autonoma De Madrid, Madrid, Spain., Ishimori M; Rheumatology, Cedars-Sinai Medical Center, Los Angeles, California, USA., Jonsson H; Rheumatology, Landspitali, Reykjavik, Iceland., Kroon FP; Rheumatology, Leiden University Medical Center, Leiden, Netherlands., Maheu E; Faculty of Medicine Pierre & Marie Curie Paris VI, Hopital Saint-Antoine,Paris, France., Ramonda R; Rheumatology Unit, Department of Medicine-DIMED, University of Padova School of Medicine and Surgery, Padova, Italy., Ritschl V; Section for Outcomes Research, Center for Medical Statistics, Informatics, and Intelligent Systems, Medical University of Vienna, Wien, Austria., Stamm TA; Section for Outcomes Research, Center for Medical Statistics, Informatics, and Intelligent Systems, Medical University of Vienna, Wien, Austria., van der Heijde D; Rheumatology, Leiden University Medical Center, Leiden, Netherlands., Wittoek R; Rheumatology, University Hospital Ghent, Gent, Belgium., Greibrokk E; Rheumatology, Diakonhjemmet Hospital, Oslo, Norway., Smeets W; Rheumatology, Leiden University Medical Center, Leiden, Netherlands., Kloppenburg M; Rheumatology, Leiden University Medical Center, Leiden, Netherlands.

Publikováno v: RMD open [RMD Open] 2020 Jun; Vol. 6 (2).